Pia Sonneveld

20082019
If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2008 2019

Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study

Moreau, P., Attal, M., Hulin, C., Arnulf, B., Belhadj, K., Benboubker, L., Béné, M. C., Broijl, A., Caillon, H. L., Caillot, D., Corre, J., Delforge, M., Dejoie, T., Doyen, C., Facon, T., Sonntag, C. C., Fontan, J., Garderet, L., Jie, K-S., Karlin, L. & 38 othersKuhnowski, F., Lambert, J. R., Leleu, X., Lenain, P., Macro, M., Mathiot, C., Orsini-Piocelle, F., Perrot, A., Stoppa, A-M., van de Donk, N. W. CJ., Wuilleme, S., Zweegman, S., Kolb, B., Touzeau, C., Roussel, M., Tiab, M., Marolleau, J-P., Meuleman, N., Vekemans, M-C., Westerman, M., Klein, S. K., Levin, M-D., Fermand, J. P., Escoffre-Barbe, M., Eveillard, J-R., Garidi, R., Ahmadi, T., Zhuang, S., Chiu, C., Pei, L., de Boer, C., Smith, E., Deraedt, W., Kampfenkel, T., Schecter, J., Vermeulen, J., Avet-Loiseau, H. & Sonneveld, P., 2019, In : The Lancet. 394, 10192, p. 29-38

Research output: Contribution to journalArticleAcademicpeer-review

Carfilzomib with immunomodulatory drugs for the treatment of newly diagnosed multiple myeloma

Landgren, O., Sonneveld, P., Jakubowiak, A., Mohty, M., Iskander, K. S., Mezzi, K. & Siegel, D. S., 2019, In : Leukemia. 33, 9, p. 2127-2143

Research output: Contribution to journalReview articleAcademicpeer-review

Open Access

Genetic correlation between multiple myeloma and chronic lymphocytic leukaemia provides evidence for shared aetiology

Went, M., Sud, A., Speedy, H., Sunter, N. J., Försti, A., Law, P. J., Johnson, D. C., Mirabella, F., Holroyd, A., Li, N., Orlando, G., Weinhold, N., van Duin, M., Chen, B., Mitchell, J. S., Mansouri, L., Juliusson, G., Smedby, K. E., Jayne, S., Majid, A. & 35 othersDearden, C., Allsup, D. J., Bailey, J. R., Pratt, G., Pepper, C., Fegan, C., Rosenquist, R., Kuiper, R., Stephens, O. W., Bertsch, U., Broderick, P., Einsele, H., Gregory, W. M., Hillengass, J., Hoffmann, P., Jackson, G. H., Jöckel, K-H., Nickel, J., Nöthen, M. M., da Silva Filho, M. I., Thomsen, H., Walker, B. A., Broyl, A., Davies, F. E., Hansson, M., Goldschmidt, H., Dyer, M. J. S., Kaiser, M., Sonneveld, P., Morgan, G. J., Hemminki, K., Nilsson, B., Catovsky, D., Allan, J. M. & Houlston, R. S., 2019, In : Blood cancer journal. 9, 1, 1.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

High subclonal fraction of 17p deletion is associated with poor prognosis in multiple myeloma

Thakurta, A., Ortiz, M., Blecua, P., Towfic, F., Corre, J., Serbina, N. V., Flynt, E., Yu, Z., Yang, Z., Palumbo, A., Dimopoulos, M. A., Gutierrez, N. C., Goldschmidt, H., Sonneveld, P. & Avet-Loiseau, H., 2019, In : Blood. 133, 11, p. 1217-1221

Research output: Contribution to journalArticleAcademicpeer-review

Open Access